Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (6) , 1180-1186
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (15K09494)
This publication has 38 references indexed in Scilit:
- Bortezomib: a new therapeutic option for POEMS syndromeEuropean Journal of Haematology, 2010
- Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndromeBlood, 2008
- Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeEuropean Journal of Haematology, 2008
- A modified peripheral neuropathy scale: the Overall Neuropathy Limitations ScaleJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Peripheral blood stem cell transplantation for POEMS syndromeBone Marrow Transplantation, 2002
- Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndromeBone Marrow Transplantation, 2002
- Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantationBone Marrow Transplantation, 2001
- Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndromeThe Lancet, 1996
- Plasma Cell Dyscrasia with Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin ChangesMedicine, 1980